Given our current understanding of the importance of α-synuclein propagation in the development and progression of PD pathology, mapping the evolution of changes over time and throughout the brain—particularly in dopaminergic and noradrenergic pathways—following injury is critical for advancing our understanding of disease progression in TBI patients. This evidence concerns the gene SNCA and Parkinson disease.